AIDS appearance in children is associated with the velocity of disease progression in their mothers - PubMed (original) (raw)

Clinical Trial

. 1994 Oct;170(4):1000-2.

doi: 10.1093/infdis/170.4.1000.

Affiliations

• PMID: 7930693
• DOI: 10.1093/infdis/170.4.1000

Clinical Trial

AIDS appearance in children is associated with the velocity of disease progression in their mothers

P A Tovo et al. J Infect Dis. 1994 Oct.

Abstract

Thirty-four human immunodeficiency virus type 1 (HIV-1)-infected mother-child pairs were studied from delivery, and the association between velocity of disease progression in mothers and age at AIDS appearance in their children was analyzed. Four maternal disease stages were defined, and the velocity of HIV-1 progression was calculated. Maternal clinical conditions at delivery and intervals before starting zidovudine in women and children were included in the analysis. The relative risk of the child's developing AIDS for mother's disease progression of 1 stage/year was 3.004 (95% confidence interval, 1.37-6.58, P = .006) in stepwise analysis. A maternal CD4+ cell count < or = 400/mm3 appeared to be associated with a rapid disease course in both women and children. Thus, the faster HIV-1 progressed in the mother, the quicker AIDS developed in her baby. This suggests that HIV-1 strains with comparable virulence develop in mother-child pairs, perhaps because of their similar genetically driven immune responses.

PubMed Disclaimer

Similar articles

• Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
  Bhargav H, Huilgol V, Metri K, Sundell IB, Tripathi S, Ramagouda N, Jadhav M, Raghuram N, Ramarao NH, Koka PS. Bhargav H, et al. J Stem Cells. 2012;7(3):127-53. J Stem Cells. 2012. PMID: 23619381
• Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
  Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSherry GD, O'Sullivan MJ, Van Dyke RB, Jimenez E, Rouzioux C, Flynn PM, Sullivan JL. Sperling RS, et al. N Engl J Med. 1996 Nov 28;335(22):1621-9. doi: 10.1056/NEJM199611283352201. N Engl J Med. 1996. PMID: 8965861 Clinical Trial.
• Prevention of mother-to-infant transmission of HIV-1.
  Melvin AJ, Frenkel LM. Melvin AJ, et al. Mol Med Today. 1997 Jun;3(6):242-5. doi: 10.1016/S1357-4310(97)01029-0. Mol Med Today. 1997. PMID: 9211414 Review.
• Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery.
  Blanche S, Mayaux MJ, Rouzioux C, Teglas JP, Firtion G, Monpoux F, Ciraru-Vigneron N, Meier F, Tricoire J, Courpotin C, et al. Blanche S, et al. N Engl J Med. 1994 Feb 3;330(5):308-12. doi: 10.1056/NEJM199402033300502. N Engl J Med. 1994. PMID: 7904046
• Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
  Sturt AS, Dokubo EK, Sint TT. Sturt AS, et al. Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Cochrane Database Syst Rev. 2010. PMID: 20238370 Review.

Cited by

• Immune activation and paediatric HIV-1 disease outcome.
  Roider JM, Muenchhoff M, Goulder PJ. Roider JM, et al. Curr Opin HIV AIDS. 2016 Mar;11(2):146-55. doi: 10.1097/COH.0000000000000231. Curr Opin HIV AIDS. 2016. PMID: 26679413 Free PMC article. Review.
• Mortality trends in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
  Kapogiannis BG, Soe MM, Nesheim SR, Abrams EJ, Carter RJ, Farley J, Palumbo P, Koenig LJ, Bulterys M. Kapogiannis BG, et al. Clin Infect Dis. 2011 Nov;53(10):1024-34. doi: 10.1093/cid/cir641. Clin Infect Dis. 2011. PMID: 22002982 Free PMC article.
• Modulation of different human immunodeficiency virus type 1 Nef functions during progression to AIDS.
  Carl S, Greenough TC, Krumbiegel M, Greenberg M, Skowronski J, Sullivan JL, Kirchhoff F. Carl S, et al. J Virol. 2001 Apr;75(8):3657-65. doi: 10.1128/JVI.75.8.3657-3665.2001. J Virol. 2001. PMID: 11264355 Free PMC article.
• Human immunodeficiency virus type 1 genetic evolution in children with different rates of development of disease.
  Ganeshan S, Dickover RE, Korber BT, Bryson YJ, Wolinsky SM. Ganeshan S, et al. J Virol. 1997 Jan;71(1):663-77. doi: 10.1128/JVI.71.1.663-677.1997. J Virol. 1997. PMID: 8985398 Free PMC article.
• Frequent perinatal transmission of feline immunodeficiency virus by chronically infected cats.
  O'Neil LL, Burkhard MJ, Hoover EA. O'Neil LL, et al. J Virol. 1996 May;70(5):2894-901. doi: 10.1128/JVI.70.5.2894-2901.1996. J Virol. 1996. PMID: 8627764 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Silverchair Information Systems

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program